Prolactin Levels After Switching to Paliperidone Palmitate in Patients with Schizophrenia

| June 1, 2016 | 0 Comments

Nakamura_May_June_2016_Artby Masaru Nakamura, MD, PhD; Takahiko Nagamine, MD, PhD; Goro Sato, MD, PhD; and Kazue Besho, Phc

Dr. Nakamura is with the Department of Psychiatric Internal Medicine, Kosekai-Kusatsu Hospital, Hiroshima, Japan; Dr. Nagamine is with the Department of Psychiatric Internal Medicine, Shinseikai-Ishii Memorial Hospital, Iwakuni, Japan; Dr. Sato is with the Department of Psychiatry, Kosekai-Kusatsu Hospital, Hiroshima, Japan; and PhC. Besho is with the Department of Pharmacy, Kosekai-Kusatsu Hospital, Hiroshima, Japan.

Innov Clin Neurosci. 2016;13(5–6):28–30

The content you are trying to view is restricted to registered members only.
Membership to Innovations in Clinical Neuroscience is free, so please consider becoming a member today.
Thank you
ICNS Online Editor
Please Login or Register for access.

Tags: , , , ,

Category: Original Research, Past Articles, Psychiatry, Psychopharmacology, Schizophrenia

Leave a Reply

This site uses Akismet to reduce spam. Learn how your comment data is processed.